FDA Drug Application (206321) for SAXENDA by NOVO NORDISK INC

Back to FDA Applications sponsored by NOVO NORDISK INC

Application Number206321
Product Number001
FormSOLUTION;SUBCUTANEOUS
Dosage18MG/3ML (6MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSAXENDA
Active IngredientLIRAGLUTIDE RECOMBINANT

Active IngredientCount
List of drugs with Active Ingredient LIRAGLUTIDE RECOMBINANT2


Back to FDA Applications sponsored by NOVO NORDISK INC